Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J5DL
|
|||
| Former ID |
DIB007765
|
|||
| Drug Name |
L-4-OXALYSINE
|
|||
| Synonyms |
I-677; Oxalysine-L; O-(2-Aminoethyl)-L-serine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H12N2O3
|
|||
| Canonical SMILES |
C(COCC(C(=O)O)N)N
|
|||
| InChI |
1S/C5H12N2O3/c6-1-2-10-3-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1
|
|||
| InChIKey |
SLTGLTLBIVDQKE-BYPYZUCNSA-N
|
|||
| CAS Number |
CAS 15219-97-3
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:72341
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histone synthesis (Histone synth) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008265) | |||
| REF 2 | Immunostimulatory action of L-4-oxalysine counteracts immunosuppression induced by alpha-fetoprotein. Eur J Pharmacol. 1998 Jun 12;351(1):105-11. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.